STAT

MARCH 27, 2025

as the nation’s health secretary last month on the condition that Kennedy, a longtime vaccine critic, keep him apprised of agency actions, especially those related to vaccines.  Bill Cassidy, the chairman of the Senate health committee, voted to confirm Robert F. Kennedy Jr.    Read the rest…

Vaccines 352

Vaccines Immunization Immunity 352

STAT

MAY 29, 2025

Calls to increase vaccine exemptions in schools and daycare centers, for example, have contributed to measles outbreaks in Texas and elsewhere. Misinformation spreads faster than prairie fire, often with as much destruction. But opponents of these bills should not give up.

Vaccines 310

Vaccines 310

STAT

MAY 28, 2025

Yet Tuesday’s decision to change the CDC vaccine recommendations, as well as new policy made last week about the way Covid shots would be regulated, takes these mistakes and amplifies them.  At the time, they railed against decisions that they said were made without medical evidence or the consultation of important experts.

Vaccines 363

Vaccines 363

PharmaVoice

JULY 9, 2025

Today, we’re speaking to Simone Steiner, Transgene’s new chief technology officer, about how the company is transitioning from early- to late-stage testing and advancing its manufacturing capabilities Oncology vaccines are gaining traction in the clinic as potential game changing treatments for cancer.

Vaccines 232

Vaccines Immunization Immunity Drug Development 232

STAT

JUNE 24, 2025

Today, we talk about the readout of Compass Pathways’ psilocybin trial for major depressive disorder, see more vaccine concern and turnover at the FDA, and report from the American Diabetes Association.    Sign up  to get our biotech newsletter in your inbox.

Vaccines 243

Vaccines Immunization Immunity Diabetes 243

Pharma Times

JULY 10, 2025

The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses. The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses.

Vaccines 81

Vaccines Immunization Immunity 81

Beckers Hospital Review

JULY 9, 2025

health insurers to preserve existing vaccine coverage without increasing patient cost-sharing. The groups emphasized that the scientific consensus supporting vaccinations as essential tools for disease prevention remains unchanged.

Vaccines 93

Vaccines Immunization Immunity Hospitals 93

The Pharmacist

JULY 3, 2025

Community pharmacies will be able to provide the HPV vaccine from 2026 to those who missed out at school, according to the government’s 10-year health plan, published today.

Community Pharmacies 52

Community Pharmacies Vaccines Diabetes 52

Pharmacy Times

JULY 17, 2025

The FDA approves a prefilled syringe for the zoster vaccine recombinant, enhancing shingles vaccination convenience and effectiveness for adults 50 and older.

Vaccines 44

Vaccines 44

Pharmacy Times

JULY 16, 2025

The shift away from thimerosal may increase the use of single-dose syringes, impacting vaccination practices in various healthcare settings. ACIP's recommendations are increasingly significant for pharmacies, influencing vaccination planning, billing, and patient care activities.

Vaccines 40

Vaccines Insurance Coverage and Processing Pharmacy Technician Community Pharmacies 40

Express Pharma

JULY 2, 2025

Multinational pharmaceutical companies (MNCs) are facing significant challenges in China’s vaccine market, as regulatory scrutiny, domestic competition, and changing consumer behaviours disrupt a once-thriving sector. The post Vaccine sales plummet in China, posing a challenge for big pharma: GlobalData appeared first on Express Pharma.

Vaccines 59

Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

Pharmafile

JULY 15, 2025

French biopharma, Osivax, has announced positive results from its phase 2 study, OVX836-004, into OVX836, its broad-spectrum influenza vaccine lead candidate. The results have been published in the journal, Vaccines.

Vaccines 59

Vaccines 59

Pharmacy Times

JULY 17, 2025

An expert discusses how pharmacists can ensure completion of multidose pneumococcal vaccine series through electronic reminder systems, state immunization registries, scheduled follow-up appointments, and providing patients with printed vaccine cards for tracking purposes.

Vaccines 26

Vaccines Immunity Immunization 26

Pharmacy Times

JULY 10, 2025

An expert discusses how pharmacists can overcome common vaccination barriers by addressing misconceptions about vaccine necessity, making strong provider recommendations, and educating patients about mild adverse effects while building trust through consistent communication.

Vaccines 26

Vaccines Communication 26

Pharmacy Times

JULY 3, 2025

An expert discusses how pharmacists should follow CDC immunization schedules for different age groups and use shared clinical decision-making for patients with prior vaccination history, while considering contraindications primarily related to severe allergic reactions to vaccine components.

Vaccines 26

Vaccines Immunity Immunization 26

Pharmacy Times

JULY 11, 2025

Panelists discuss that building trust with vaccine-hesitant patients requires pharmacists to slow down, listen empathetically, and ask open-ended questions to understand individual concerns; by addressing specific fears with clear, tailored information and practicing cultural sensitivity, pharmacists can foster ongoing, respectful dialogue that gradually (..)

Vaccines 26

Vaccines 26

Pharma Times

JULY 1, 2025

The vaccine showed a 26.6% higher relative vaccine efficacy compared with the existing option. Across all age groups, risk profiles and vaccination histories, the results were consistently strong. The severity of this past flu season underscores the need for more effective vaccines.” for A/H1N1, 22.2% for B/Victoria.

Vaccines 78

Vaccines Adverse Reactions 78

Pharmacy Times

JULY 11, 2025

Panelists discuss the 3 FDA-approved RSV vaccines for high-risk adults—2 recombinant protein-based (1 adjuvanted, 1 bivalent) and one mRNA-based—highlighting differences in formulation, mechanism, and preparation, and emphasizing the importance of education to address misconceptions and guide appropriate vaccine selection.

Vaccines 26

Vaccines 26

Express Pharma

JUNE 25, 2025

Bharat Biotech International (BBIL) and GSK plc have announced a joint pledge to Gavi, the Vaccine Alliance, as part of the continued global roll-out of the RTS,S malaria vaccine. The companies confirmed a phased reduction in the vaccine’s price to below USD 5 by 2028.

Vaccines 66

Vaccines 66

Pharmacy Times

JULY 9, 2025

In a community of older adults, initiating a pneumococcal vaccination support program reduced annual pneumonia-related mortality by 25%, demonstrating broad public and individual health benefits.

Vaccines 29

Vaccines 29

Pharmacy Times

JULY 11, 2025

Panelists discuss recent safety updates on RSV vaccines, including a rare potential risk of Guillain-Barré syndrome (GBS) in older adults receiving recombinant vaccines, emphasizing that benefits outweigh risks and highlighting the pharmacist’s role in educating patients about common adverse effects, recognizing early signs of rare adverse events, (..)

Vaccines 26

Vaccines 26

Pharmacy Times

JULY 15, 2025

Adam James, PharmD, and Chris Altman, PharmD, discuss renewed public scrutiny of thimerosal, its limited use in vaccines today, and how new guidance may affect pharmacists and patient confidence moving forward.

Vaccines 20

Vaccines 20

Pharmacy Times

JULY 11, 2025

Panelists discuss how community pharmacies have become trusted hubs for adult vaccinations, with pharmacists not only administering vaccines but also educating patients and coordinating with other health care providers to ensure clear, unified messaging; they emphasize the importance of collaboration, empowering pharmacists to use clinical judgment, (..)

Vaccines 26

Vaccines Community Pharmacies 26

Pharmacy Times

JULY 11, 2025

Panelists discuss how pharmacists can address patients’ growing vaccine fatigue and misconceptions—such as underestimating RSV’s severity in adults or believing it requires multiple doses—by providing clear, consistent education and emphasizing that a single RSV vaccine offers protection against serious illness in high-risk populations.

Vaccines 26

Vaccines 26

Pharmacy Times

JULY 8, 2025

New research reveals that extracellular vesicles enhance intranasal flu vaccines, boosting mucosal immunity and offering broader protection against diverse strains.

Vaccines 26

Vaccines Immunity Immunization 26

Pharmacy Times

JUNE 20, 2025

Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period. 1,2 A particular disease burden is present for Black Americans.

Vaccines 29

Vaccines Pharmacy Technician Immunization Immunity 29

Pharmacy Times

JULY 10, 2025

An expert discusses how pharmacists can evaluate patients with prior adverse vaccine reactions by distinguishing between mild local reactions and serious anaphylactic responses, then recommending supervised vaccination or medical center administration when appropriate.

Vaccines 26

Vaccines 26

Pharmacy Times

JUNE 24, 2025

Six years following vaccination with 23-valent pneumococcal polysaccharide vaccine in a Chinese population, antibody levels remained high, though not as high as 28 days following vaccination.

Vaccines 29

Vaccines 29

Pharmaceutical Technology

JUNE 20, 2025

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. Credit: Department of Health Abu Dhabi.

Vaccines 52

Vaccines Pharmaceutical Manufacturing Communication Hospitals 52

Pharmacy Times

JUNE 27, 2025

With the Advisory Committee on Immunization Practices recommending that adults receive thimerosal-free influenza vaccines, the preservative that was phased out of most childhood vaccines in 2001 has reentered the public eye.

Vaccines 45

Vaccines Immunity Immunization 45

Pharmacy Times

JULY 11, 2025

Panelists discuss vaccine hesitancy surrounding the new RSV vaccine, highlighting factors such as uncertainty about safety and effectiveness, cost concerns, limited health literacy, language barriers, and lingering skepticism fueled by the COVID-19 pandemic, emphasizing how pharmacists can address these issues through tailored education, insurance (..)

Vaccines 32

Vaccines Communication 32

Pharmacy Times

JUNE 24, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician 26

Pharmacy Technician Diabetes Inpatient Compounding Pharmacies 26

Pharmacy Times

JULY 10, 2025

Annie Eisenbeis, PharmD, MBA, showcased how Missouri’s Pharmacy Vaccine Gap Closure Program is transforming pharmacy-based immunization services through scalable workflows, team training, and a redefined role for pharmacy technicians as community health workers.

Pharmacy Technician 20

Pharmacy Technician Vaccines Immunity Immunization 20

Pharmacy Times

JULY 11, 2025

Panelists discuss that pharmacies should prioritize practical workflow and patient management over clinical preference when administering RSV vaccines, since all FDA-approved vaccines are equally recommended; focusing on factors like preparation ease, storage, patient eligibility, and insurance helps streamline operations and promote timely vaccination (..)

Vaccines 26

Vaccines 26

Pharmacy Times

JULY 16, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

HIV Treatment and Prevention Agents 26

HIV Treatment and Prevention Agents Pharmacy Technician Diabetes Compounding Pharmacies 26

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 29

Express Pharma

JUNE 19, 2025

Indian pharmaceutical companies supply more than 60 per cent of global demand for vaccines and over 40 per cent of generic medicines consumed in the United States (2). This growth is further driven by global shortages of sterile products, an expanding biologics pipeline, and the demand for emergency-use therapies including vaccines.

Documentation 104

Documentation Vaccines Pharmaceutical Companies Pharmaceutical Companies 104